Simplex Trading’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-9,482
| Closed | -$23K | – | 10648 |
|
|
2020
Q4 | $23K | Buy |
+9,482
| New | +$23.1K | ﹤0.01% | 6894 |
|
|
2020
Q2 | – | Sell |
-3,518
| Closed | -$11.1K | – | 8880 |
|
|
2020
Q1 | $9K | Buy |
+3,518
| New | +$11.3K | ﹤0.01% | 6579 |
|
|
2019
Q3 | – | Sell |
-2,997
| Closed | -$8.01K | – | 8362 |
|
|
2019
Q2 | $9K | Sell |
2,997
-1,224
| -29% | -$3.97K | ﹤0.01% | 6203 |
|
|
2019
Q1 | $15K | Buy |
+4,221
| New | +$14.3K | ﹤0.01% | 5918 |
|
|
2018
Q3 | – | Sell |
-20,607
| Closed | -$50.6K | – | 8633 |
|
|
2018
Q2 | $48K | Buy |
+20,607
| New | +$57.5K | ﹤0.01% | 5108 |
|
|
2018
Q1 | – | Sell |
-5,424
| Closed | -$14.8K | – | 7522 |
|
|
2017
Q4 | $14K | Sell |
5,424
-21,830
| -80% | -$67.1K | ﹤0.01% | 3656 |
|
|
2017
Q3 | $92K | Buy |
+27,254
| New | +$75.8K | ﹤0.01% | 1788 |
|
|
2016
Q4 | – | Sell |
-22,131
| Closed | -$61.8K | – | 7197 |
|
|
2016
Q3 | $74K | Sell |
22,131
-7,110
| -24% | -$22.6K | 0.01% | 1789 |
|
|
2016
Q2 | $91K | Buy |
+29,241
| New | +$97.5K | 0.01% | 1552 |
|
|
2015
Q4 | – | Sell |
-2,816
| Closed | -$11.8K | – | 6926 |
|
|
2015
Q3 | $14K | Buy |
+2,816
| New | +$16.1K | ﹤0.01% | 3165 |
|
|
2015
Q2 | – | Sell |
-18,357
| Closed | -$123K | – | 6533 |
|
|
2015
Q1 | $129K | Buy |
18,357
+18,308
| +37,363% | +$133K | 0.02% | 946 |
|
|
2014
Q4 | $0 | Buy |
+49
| New | +$388 | ﹤0.01% | 4679 |
|
Other funds holding PDLI
Simplex Trading's PDLI Position: Q1 2021 in Review
Simplex Trading sold out of PDL BioPharma, Inc. (PDLI) in Q1 2021, closing a stake of 9,482 shares — an estimated $23K sold.
Simplex Trading first reported a position in PDLI in Q4 2014 and held it in 12 quarters. The position peaked at $129K in Q1 2015. 11 funds tracked by Wall St. Rank hold PDLI as of Q1 2021.
- Simplex Trading reported no remaining PDL BioPharma, Inc. position as of Q1 2021 after selling out during the quarter.
- Simplex Trading sold 9,482 PDL BioPharma, Inc. shares in Q1 2021, an estimated $23K.
- Simplex Trading first reported a position in PDL BioPharma, Inc. in Q4 2014 and held it in 12 quarters.
- Simplex Trading's PDL BioPharma, Inc. position peaked at $129K in Q1 2015.
- 11 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2021.
Based on Simplex Trading's 13F filing for Q1 2021, filed 26 Apr 2021.